Literature DB >> 27716525

Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate.

Hanen Ouadani1, Imen Ben-Mustapha1, Meriem Ben-Ali1, Beya Larguèche2, Tihana Jovanic3, Sylvie Garcia4, Benoit Arcangioli5, Houda Elloumi-Zghal2, Dahmani Fathallah2, Mongia Hachicha6, Hatem Masmoudi7, François Rougeon3, Mohamed-Ridha Barbouche8.   

Abstract

Activation induced cytidine deaminase (AID) is an essential enzyme for class switch recombination (CSR) and somatic hypermutation (SHM) during secondary immune response. Mutations in the AICDA gene are responsible for Hyper IgM 2 syndrome where both CSR and SHM or only CSR are affected. Indeed, triggering either of the two mechanisms requires the DNA deamination activity of AID. Besides, different domains of AID may be differentially involved in CSR and SHM through their interaction with specific cofactors. Herein, we studied the AID-induced SHM activity of the AID-His130Pro mutant identified in a patient with Hyper IgM 2 syndrome. AID mutagenic activity was monitored by the reversion of nonsense mutations of the EGFP gene assessed by flow cytometry. We found that the His130Pro mutation, which affects CSR, preserves AID mutagenic activity. Indeed, the His130 residue is located in a putative specific CSR region in the APOBEC-like domain, known to involve CSR specific cofactors that probably play a major role in AID physiological activities. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AID mutagenic activity; Activation induced cytidine deaminase; Class switch recombination; Cofactors; Hyper IgM 2; Somatic hypermutation

Mesh:

Substances:

Year:  2016        PMID: 27716525     DOI: 10.1016/j.molimm.2016.09.025

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  3 in total

Review 1.  Single-nucleotide editing: From principle, optimization to application.

Authors:  Jinling Tang; Trevor Lee; Tao Sun
Journal:  Hum Mutat       Date:  2019-09-15       Impact factor: 4.878

Review 2.  Comprehensive review of autoantibodies in patients with hyper-IgM syndrome.

Authors:  Mohamed-Ridha Barbouche; Qubo Chen; Marco Carbone; Imen Ben-Mustapha; Zakera Shums; Mehdi Trifa; Federica Malinverno; Francesca Bernuzzi; Haiyan Zhang; Nourhen Agrebi; Gary L Norman; Christopher Chang; M Eric Gershwin; Pietro Invernizzi
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

Review 3.  Lessons from Genetic Studies of Primary Immunodeficiencies in a Highly Consanguineous Population.

Authors:  Mohamed-Ridha Barbouche; Najla Mekki; Meriem Ben-Ali; Imen Ben-Mustapha
Journal:  Front Immunol       Date:  2017-06-27       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.